registertoday to attend, click here or call: 0161 6865576

Programme
print friendly version

8:15-9:20
Coffee, Registration and Networking
9:20-11:15
MORNING PLENARY SESSION: AMR, new threat, new challenges
10:30
PDFs

Dr Nicholas Brown, President

British Society for Antimicrobial Chemotherapy (BSAC) (CONFIRMED)
10:40
Videos

Dr Kieran Hand, Consultant Pharmacist - Anti-infectives

University Hospital Southampton NHS Foundation Trust (CONFIRMED)

Professor David Walker, Deputy Chief Medical Officer

The Department of Health (DH) (CONFIRMED)

Dr Danilo Lo Fo Wong, Senior Adviser, Antimicrobial Resistance

WHO Regional Office for Europe (CONFIRMED)

Dr Nicholas Brown, President

British Society for Antimicrobial Chemotherapy (BSAC) (CONFIRMED)

Michael Holden, Chief Executive

National Pharmacy Association (CONFIRMED)

Dr Manos Perros, Global Head of Infection, Innovative Medicines, R&D Boston

AstraZeneca (CONFIRMED)
11:20-11:50
Morning Tea/Coffee and Networking
11:50-12:40
Learning and Implementation: Master Class Session 1
11:50
Theme:
Improving the treatment of CDI.

Benefits of attending:
This presentation will explain how and why fidaxomicin was added to the Guys and St Thomas Trust formulary. Although Clostridium difficile infection (CDI) cases in London as a whole seemed to be plateauing in the first half of 2012, by September 2012, it seemed that Guys and St Thomas would exceed its CDI target. To prevent this, the Trust aimed to improve antimicrobial stewardship and this included the introduction of fidaxomicin.

Summary of content:    

This presentation will explain how and why fidaxomicin was added to the Guys and St Thomas Trust formulary.
1. Understanding the clinical decision making process
2. Understanding the financial considerations and building the business case
3. Results obtained so far
11:50
VideosPDFs
Theme:
Examining the role of fabrics to improve patient dignity and comfort, and staff and visitor safety, whilst reducing HCAIs and SSIs.

Benefits of attending:
In this master class we will demonstrate not only how developments and innovations with single use fabrics can alleviate the acquisition and spread of HCAIs and SSIs, but also, how they can add to the sustainability of the NHS.

Summary of content:
1. Patient warming: a solution
2. Responsibility: where it lies
3. Less really does mean more
4. Linking innovation, sustainability and improved procurement
11:50
VideosPDFs
Theme:
Dr Mark Wilks Lead Clinical Scientist at Barts Health Trust reviews how mass spectrometry is changing diagnostic clinical microbiology, the progress that has been made, the hurdles that remain, and the exciting prospects for the future of mass spec in clinical microbiology.   

Benefits of attending:
1. Share in the unique insights of a Microbiology lab, which currently runs both of the most commonly used MALDI-TOF systems.  
2. Learn how implementation of routine identification by mass spec is changing and guiding clinical diagnosis. For example, how mass spec ID results can be used to improve empirical antibiotic therapy.  
3. Understand the limitations of the currently available commercial systems and the challenges in their adoption.  
4. Look ahead to possibilities for mass spec in clinical microbiology as the technology improves. Hear about some of the highlights of current research programmes in microbial proteomics.
11:50
VideosPDFs
Theme:
The role of a simple paper hand towel in facing the challenges of antimicrobial resistance

Benefits of attending:
1. Gain an understanding of the critical success factors in hand hygiene.
2. Learn about the most overlooked step in hand hygiene protocol and how it contributes to better hand hygiene compliance.

Summary of content:
1. Why the credentials of your supplier are important.
2. The impact of hand hygiene campaigns.
3. Whose responsibility is the choice of product?
4. Why its important not to lose sight of the basics.
5. The paper your hand towel is made of is just paper isnt it?
12:40-13:25
Learning and Implementation: Master Class Session 2
12:40
PDFs
Aims/Objectives:
Understanding what systems and processes are needed to achieve excellence
Showing you how you can transform the way you combat HCAIs

The benefits of attending:
Hearing how The Royal Liverpool & Broadgreen University Hospitals NHS Trust achieves Double Excellent from CQC
Learning how to overcome the barriers to embedding a culture of training and education
Find out how to create an Isolation Unit which starts at diagnosis

Summary of Content:
The need for agreement and consensus with Clinicians
Putting in place a process to rapidly identify and isolate patients
Reducing CDT through implementing Hydrogen Peroxide Fogging
Implementing a rolling Deep Clean initiative to drive down infection rates
Reassuring patients and commissioners that HCAIs are being reduced

Presented by:
Diane Wake, Executive Director of Nursing & Operations / Director of Infection Prevention & Control
Royal Liverpool & Broadgreen University Hospitals NHS Trust
12:40
VideosPDFs
Theme:
The link between surgeons skin flora and SSI: How a new anti-microbial technology via a surgical glove could reduce the risk.

Benefits of attending:    
Understand the added value of the anti-microbial technology in SSI prevention strategies.Access to a clinical study: Prospective, double-blind, randomised controlled single-centre trial: suppression of surgeons skin flora during surgical procedures using a new anti-microbial surgical glove.  (University Hospital of Vienna 2012) Assadian O, Kramer A, Ouriel K, Suchomel M, McLaws ML, Rottman M, Leaper D, Assadian A.

Summary of content:
1. Frequency of surgical glove perforation
2. Clinical relevance and impact of surgical glove perforation
3. Strategies to prevent surgical site infection and healthcare associated infections
12:40
VideosPDFs
Summary of content:
A successful electronic installation is just scratching the surface of an electronic hand hygiene solution. In this master class we will cover the following topics:

1. Overview of the MedSense solution
2. How to effectively engage healthcare workers to maximize benefits
3. Methods of feedback, such as reports and real time alerts, and how to best use them
4. Mining the data to gather a novel insight into your hospital operations
5. Using the data to improve compliance and patient safety
12:40
VideosPDFs

Theme:
Healthcare professionals in 5,500+ hospitals across 83 countries rely upon Truven Health MICROMEDEX Solutions in their patient safety efforts.

Summary of content:
Micromedex 360 Care Insights helps improve patient care and save costs by identifying at-risk patients for early intervention.  Working with disparate hospital systems it aggregates patient data into consolidated clinical dashboards and runs real-time clinical surveillance.

Micromedex Infection Prevention provides evidence-based clinical decision support (CDS) profiles that power real-time surveillance and automated rounding-lists which enable interventions in care to support infection prevention. It helps decrease never events, eliminate manual data reviews, and alert clinicians faster of patients at risk of developing hospital-acquired infections (HCAIs) such as C-dif, CAUTI, CLABSI, DE, MRSA, PPP, SSI and VAP.

Join David Bordewyk M.D., Clinical Solutions Executive at Truven Health Analytics, for a Masterclass on how clinical surveillance and infection control dashboards support exposure management, trend analysis and on-demand queries, generating rate reports and antibiograms to improve patient safety.
13:25-14:25
LUNCH AND NETWORKING
14:25-15:25
Learning and Implementation: Master Class Session 3
14:25
VideosPDFs
Theme:
DebMed, the worlds first evidence-based group monitoring system that electronically monitors, tracks and reports compliance rates in real-time, based on the WHOs Five Moments for Hand Hygiene.  
Benefits of attending    Learn how to increase hand hygiene compliance, improve skin condition and reduce the risk of cross-infection.

Summary of content:

1. Hospitals, long term care facilities, clinics & other healthcare service providers emphasise hand hygiene as the primary way to prevent infection.  
2. However, low compliance and increased risk of infection occurs due to:
3. Lack of availability of hand hygiene products at every point of care
4. Dry, chapped and irritated skin
5. Patient care priorities and emergencies
6. Time constraints
7. Belief by some healthcare workers that more evidence or proof is needed with regard to the impact of proper hand hygiene on HCAI rates

This master class explains how to increase hand hygiene compliance through the implementation of DebMed.
14:25
VideosPDFs
Summary of Content:
The role of wound dressings in the prevention and treatment of wound infection is a much debated subject. There are polarised opinions on the efficacy of using advanced antimicrobial wound dressings and questions asked about the role of specialist nurses in helping to reduce or eliminate HAIs.

Aspen Medical is pleased to support this event and during this session will endeavour to provide an insight into the experienced clinicians, academic and industry viewpoints. Our speaker will also provide supporting evidence for the considered use of topical antimicrobial products and reference best practice consensus papers in addition to providing an overview of key antimicrobial technologies used in the treatment of wound infection.  

Aspens woundcare division provides a comprehensive range of innovative dressings for the management of acute and chronic wounds. Our products are cost effective and the technologies are designed to improve healing rates, manage complex wounds and treat infected wounds.
14:25
VideosPDFs
Theme:
How MRSA and other transmissions can be traced in a hospital setting using NGS

Benefits of attending:
Learn how Illuminas next generation sequencing (NGS) enables researchers and health care professionals to track genetic mutations in pathogen genomes during the course of a disease outbreak, making it possible to identify where particular variants arose and trace person-to-person transmission events.

Summary of content:
1. Basic introduction to Illumina and next generation sequencing technology
2. Whole genome sequencing to dissect the cause and effect of an MRSA outbreak
14:25
VideosPDFs
Theme:
Refurbishment and upgrading of operating theatre and clinical areas needs to be targeted to providers who have the experience and expertise to fulfil the questions of infection control, applicable resolution of issues and fulfill national standards all within one cost effective solution. BUY CHEAP - BUY TWICE

Summary of content:
Why refurbish? Why upgrade?
1. Replacement of outdated and/or failing facilities
2. Environmental systems
3. Structure
4. Clinical equipment

Changes in types of surgical methods
1. Robotics/Hybrid CT Scanning/Minimally Invasive technology
15:25-15:40
Afternoon Tea/Coffee and Networking
15:40-16:50
AFTERNOON PLENARY SESSION: Diagnosing the threat
15:45
Videos
This afternoon debate will bring together experts from across all field of infection control and highlight, discuss and examine the threats outside of the MRSA and C.difficile sphere. With mandatory surveillance, media attention and a greater emphasis being placed on MRSA and C.difficile infections such as norovirus, ecoli, salmonella, pseudomonas and legionella have continued to cause pain and suffering to both patients and relatives.
16:45-16:55
Chair's Concluding Comments

Add comment


Security code
Refresh

 

MAIN SPONSOR

IN ASSOCIATION WITH

British Society for Antimicrobial Chemotherapy (BSAC)

MEDIA PARTNER

Clinical Services Journal

CONFERENCE SUPPORTERS

MRSA Action UK Association of Healthcare Cleaning Professionals (AHCP) Independent Healthcare Advisory Services Intensive Care Society

LATEST SPEAKER

Michael Holden

Michael Holden

Chief Executive
National Pharmacy Association

Michael Holden read pharmacy at Portsmouth School of Pharmacy. He was awarded a BSc Pharm in 1976 and did his pre-registration year in Lancashire.

Following a number of years in various... Read more

LATEST DELEGATES

  • Consultant Microbiologist

    Maidstone and Tunbridge Wells NHS Trust

  • Senior Biomedical Scientist - Microbiology

    Epsom and St Helier University Hospitals NHS Trust

  • Lead For Infection Control

    Spire Portsmouth Hospital

  • Infection Prevention Lead

    BMI Healthcare

  • Infection Control Surveillance Team Leader

    Guys & St Thomas NHS Foundation Trust

  • CNS Infection Prevention and Control

    North East London NHS Foundation Trust

  • Senior Biomedical Scientist - Microbiology

    Imperial College Healthcare NHS Trust

  • Healthcare Assistant

    Homerton University Hospital NHS Foundation Trust

  • Staff Nurse - Ward 2

    Grays Court Community Hospital

  • Director of Clinical Services

    BMI Healthcare